SS
CSTL icon

SBI Securities’s Castle Biosciences CSTL Stock Holding History

SBI Securities’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12K Hold
47
– – ﹤0.01% 2765
2026
Q1 		$1.15K Sell
47
-5
-10% -$164 ﹤0.01% 2606
2025
Q4 		$2.02K Sell
52
-1
-2% -$32 ﹤0.01% 2372
2025
Q3 		$1.21K Buy
53
+3
+6% +$61 ﹤0.01% 2612
2025
Q2 		$1.02K Sell
50
-8
-14% -$148 ﹤0.01% 2672
2025
Q1 		$1.16K Buy
58
+8
+16% +$198 ﹤0.01% 2513
2024
Q4 		$1.33K Buy
+50
New +$1.52K ﹤0.01% 2482

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's CSTL Position: Q2 2026 in Review

SBI Securities held its Castle Biosciences (CSTL) position steady in Q2 2026 at 47 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

SBI Securities first reported a position in CSTL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.02K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • SBI Securities held 47 shares of Castle Biosciences worth $1.12K as of Q2 2026.
  • SBI Securities left its Castle Biosciences share count unchanged in Q2 2026.
  • Castle Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2765 holding.
  • SBI Securities first reported a position in Castle Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Castle Biosciences position peaked at $2.02K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.